Literature DB >> 2538324

Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.

E Abemayor1, N Sidell.   

Abstract

Neuroblastoma is a childhood solid tumor composed of primitive cells derived from precursors of the autonomic nervous system. This neoplasm has the highest rate of spontaneous regression of all cancer types and has been noted to undergo spontaneous and chemically induced differentiation into elements resembling mature nervous tissue. As such, neuroblastoma has been a prime model system for the study of neuronal differentiation and the process of cancer cell maturation. In this paper we review those agents that have been described to induce the differentiation of neuroblastoma, with an emphasis on the effects and possible mechanisms of action of a group of related compounds, the retinoids. With this model system and the availability of subclones that are both responsive and resistant to chemically induced differentiation, fundamental questions regarding the mechanisms and processes underlying cell maturation have become more amenable to in vitro study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538324      PMCID: PMC1567609          DOI: 10.1289/ehp.89803

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  131 in total

Review 1.  The migration and differentiation of neural crest cells.

Authors:  J A Weston
Journal:  Adv Morphog       Date:  1970

2.  Expression of N-myc and c-src during the development of fetal human brain.

Authors:  E F Grady; M Schwab; W Rosenau
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Investigational chemotherapy of neuroblastoma.

Authors:  L Helson
Journal:  J Fla Med Assoc       Date:  1979-03

5.  B cell activation. VI. Effects of exogenous diglyceride and modulators of phospholipid metabolism suggest a central role for diacylglycerol generation in transmembrane signaling by mIg.

Authors:  K M Coggeshall; J C Cambier
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

6.  Identification and quantitation of intracellular retinol and retinoic acid binding proteins in cultured cells.

Authors:  M R Haussler; C A Donaldson; M A Kelly; D J Mangelsdorf; G T Bowden; W J Meinke; F L Meyskens; N Sidell
Journal:  Biochim Biophys Acta       Date:  1984-02-17

7.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  An early decrease in phosphatidylinositol turnover occurs on induction of Friend cell differentiation and precedes the decrease in c-myc expression.

Authors:  D L Faletto; A S Arrow; I G Macara
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

9.  Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3':5'-monophosphate and testosterone.

Authors:  A W Hsie; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  The effect of nerve growth factor on the development of sodium channels in PC12 cells.

Authors:  J K Reed; D England
Journal:  Biochem Cell Biol       Date:  1986-11       Impact factor: 3.626

View more
  46 in total

1.  Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells.

Authors:  A K Hall
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

2.  The enhancement of growth and differentiation of rat adrenal nerve cells by the addition of conditioned medium from human fibroblast cultures.

Authors:  J S Hong; D S Kim; S H Kim; D H Choi; J H Lee; H Y Lee
Journal:  Cytotechnology       Date:  1998-03       Impact factor: 2.058

3.  The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.

Authors:  Anna Lasorella; Antonio Iavarone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

4.  Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.

Authors:  Yavuz Dodurga; Gulsah Gundogdu; Volkan Tekin; Tugba Koc; N Lale Satiroglu-Tufan; Gulseren Bagci; Vural Kucukatay
Journal:  Mol Biol Rep       Date:  2014-03-21       Impact factor: 2.316

5.  Phenotypic and morphological characterization of neuroblastoma cells constitutively expressing B-myb.

Authors:  S Scarpa; A Negroni; R Amendola; P Signorelli; B Calabretta; A Modesti; G Raschellà
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

6.  Nav2 is necessary for cranial nerve development and blood pressure regulation.

Authors:  Elizabeth M McNeill; Kenneth P Roos; Dieder Moechars; Margaret Clagett-Dame
Journal:  Neural Dev       Date:  2010-02-25       Impact factor: 3.842

7.  Electromagnetic information delivery as a new tool in translational medicine.

Authors:  Foletti Alberto; Ledda Mario; Piccirillo Sara; Grimaldi Settimio; Lisi Antonella
Journal:  Int J Clin Exp Med       Date:  2014-09-15

8.  Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.

Authors:  Eunsil Yu; Eun Kyung Choi; Chong Jai Kim
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

Review 9.  Biology of pediatric peripheral neuroectodermal tumors.

Authors:  C J Thiele
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

10.  FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.

Authors:  Weidong Han; Zhiqiang Wu; Yali Zhao; Yuanguang Meng; Yiling Si; Jie Yang; Xiaobing Fu; Li Yu
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.